{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:19:36Z","timestamp":1778782776296,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013275","name":"Instituto Serrapilheira","doi-asserted-by":"publisher","award":["1708-16250"],"award-info":[{"award-number":["1708-16250"]}],"id":[{"id":"10.13039\/501100013275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/07600-3"],"award-info":[{"award-number":["2013\/07600-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/18192-9"],"award-info":[{"award-number":["2015\/18192-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/19712-9"],"award-info":[{"award-number":["2016\/19712-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/05130-3"],"award-info":[{"award-number":["2018\/05130-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["151058\/2018-0"],"award-info":[{"award-number":["151058\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307132\/2016-1"],"award-info":[{"award-number":["307132\/2016-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405330\/2016-2"],"award-info":[{"award-number":["405330\/2016-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.sbi.2019.02.014","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:59:39Z","timestamp":1554418779000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Structural and mechanistic insight from antiviral and antiparasitic enzyme drug targets for tropical infectious diseases"],"prefix":"10.1016","volume":"59","author":[{"given":"Andre Schutzer","family":"de Godoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela","family":"Sachetto Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Caroline","family":"Campos Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Vieira Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalya Cristina","family":"de Moraes Roso Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Victorio","family":"Carvalho Guido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaucius","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2019.02.014_sbref0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2019.02.014_bib0010","series-title":"World Malaria Report 2018","article-title":"Report describing the heath and economical impact of malaria around the world in 2018.","year":"2019"},{"key":"10.1016\/j.sbi.2019.02.014_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-018-0327-4","article-title":"Challenges and recent progress in tropical disease drug discovery","volume":"559","author":"De Rycker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2019.02.014_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2019.02.014_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/v10020089","article-title":"The alphavirus exit pathway: what we know and what we wish we knew","volume":"10","author":"Brown","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.sbi.2019.02.014_bib0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.tim.2018.05.012","article-title":"Yellow fever virus: knowledge gaps impeding the fight against an old foe","volume":"26","author":"Douam","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2019.02.014_bib0040","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2019.02.014_bib0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.sbi.2019.02.014_bib0055","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus ns3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sbi.2019.02.014_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B\u2013NS3 protease\u2013helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.sbi.2019.02.014_bib0065","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.3390\/v7082837","article-title":"Flaviviral replication complex: coordination between RNA synthesis and 51-RNA capping","volume":"7","author":"Klema","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.sbi.2019.02.014_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.sbi.2019.02.014_bib0075","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1021\/jm0607606","article-title":"Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors","volume":"49","author":"Knox","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_bib0080","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/jm800503y","article-title":"Potent cationic inhibitors of West Nile virus NS2B\/NS3 protease with serum stability, cell permeability and antiviral activity","volume":"51","author":"Stoermer","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide\u2013boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.sbi.2019.02.014_bib0095","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A","volume":"79","author":"Xu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0100","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","article-title":"Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing","volume":"79","author":"Wu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s13238-016-0275-4","article-title":"The crystal structure of Zika virus helicase: basis for antiviral drug design","volume":"7","author":"Tian","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.sbi.2019.02.014_bib0110","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sbi.2019.02.014_bib0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/id5000458","article-title":"Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase","volume":"1","author":"Sweeney","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.sbi.2019.02.014_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","article-title":"The dengue virus NS5 protein as a target for drug discovery","volume":"119","author":"Lim","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.sbi.2019.02.014_bib0125","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","article-title":"Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design","volume":"59","author":"Yokokawa","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_bib0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1\u20134 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.sbi.2019.02.014_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sbi.2019.02.014_bib0140","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1056\/NEJMc1611829","article-title":"Perioperative ledipasvir\u2013sofosbuvir for HCV in liver-transplant recipients","volume":"375","author":"Levitsky","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.sbi.2019.02.014_bib0150","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0155","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2019.02.014_bib0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09797-8","article-title":"Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae","volume":"7","author":"Ferreira","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2019.02.014_bib0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/rmv.681","article-title":"Chikungunya virus: host pathogen interaction","volume":"21","author":"Singh","year":"2011","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0170","first-page":"1","article-title":"Nonstructural proteins of alphavirus - potential targets for drug development","volume":"10","author":"Bakar","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.sbi.2019.02.014_bib0175","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1016\/j.bmc.2017.06.049","article-title":"The medicinal chemistry of chikungunya virus","volume":"25","author":"da Silva-J\u00fanior","year":"2017","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_bib0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2675","article-title":"Conventional and unconventional mechanisms for capping viral mRNA","volume":"10","author":"Decroly","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152609787847712","article-title":"Antiviral treatment of chikungunya virus infection","volume":"9","author":"de Lamballerie","year":"2009","journal-title":"Infect Disord - Drug Targets"},{"key":"10.1016\/j.sbi.2019.02.014_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep31819","article-title":"The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection","volume":"6","author":"Delang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.sbi.2019.02.014_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2013.01.002","article-title":"Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus","volume":"98","author":"Bassetto","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.sbi.2019.02.014_bib0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmc.2018.01.002","article-title":"Design, synthesis and evaluation against chikungunya virus of novel small-molecule antiviral agents","volume":"26","author":"Tardugno","year":"2018","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0205","first-page":"e01389","article-title":"Beyond members of the flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","volume":"63","author":"Ferreira","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0210","doi-asserted-by":"crossref","DOI":"10.1177\/1178636118808529","article-title":"Exploration of the Plasmodium falciparum resistome and druggable genome reveals new mechanisms of drug resistance and antimalarial targets","volume":"11","author":"Cowell","year":"2018","journal-title":"Microbiol insights"},{"key":"10.1016\/j.sbi.2019.02.014_bib0215","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","article-title":"Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study","volume":"18","author":"Llanos-Cuentas","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sbi.2019.02.014_sbref0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sbi.2019.02.014_bib0230","unstructured":"Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model - ClinicalTrials.gov. Accessed 15 February 2019."},{"key":"10.1016\/j.sbi.2019.02.014_bib0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baraga\u00f1a","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2019.02.014_bib0240","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers","volume":"69","author":"Morillo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.sbi.2019.02.014_bib0245","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.sbi.2019.02.014_bib0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.exppara.2016.01.007","article-title":"Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes","volume":"163","author":"Petri e Silva","year":"2016","journal-title":"Exp Parasitol"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X19300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X19300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:06:23Z","timestamp":1778781983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X19300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":50,"alternative-id":["S0959440X19300272"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2019.02.014","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and mechanistic insight from antiviral and antiparasitic enzyme drug targets for tropical infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sbi.2019.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}